12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Boniva ibandronate regulatory update

FDA said it approved the first generic versions of once-monthly Boniva ibandronate 150 mg tablets to treat and prevent postmenopausal...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >